Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

B. Riley Securities cut Ciena Corporation CIEN price target from $97 to $89. B. Riley Securities analyst Dave Kang maintained a Buy rating. Ciena shares closed at $63.95 on Tuesday. See how other analysts view this stock.
Truist Securities boosted the price target for Expedia Group, Inc. EXPE from $163 to $175. Truist Securities analyst Greg Miller maintained a Hold rating. Expedia shares closed at $163.75 on Tuesday. See how other analysts view this stock.
JP Morgan cut Tesla, Inc. TSLA price target from $135 to $120. JP Morgan analyst Ryan Brinkman maintained an Underweight rating. Tesla shares closed at $230.58 on Tuesday. See how other analysts view this stock.
Raymond James slashed the price target for Diamondback Energy, Inc. FANG from $245 to $214. Raymond James analyst John Freeman maintained a Strong Buy rating. Diamondback Energy shares closed at $144.65 on Tuesday. See how other analysts view this stock.
DA Davidson cut the price target for RumbleOn, Inc. RMBL from $5 to $4. DA Davidson analyst Michael Baker maintained a Neutral rating. RumbleOn shares closed at $3.59 on Tuesday. See how other analysts view this stock.
Susquehanna cut Teradyne, Inc. TER price target from $165 to $155. Susquehanna analyst Mehdi Hosseini maintained a Positive rating. Teradyne shares settled at $87.07 on Tuesday. See how other analysts view this stock.
RBC Capital slashed Illumina, Inc. ILMN price target from $247 to $128. RBC Capital analyst Conor McNamara maintained an Outperform rating. Illumina shares closed at $84.52 on Tuesday. See how other analysts view this stock.
Macquarie cut Vail Resorts, Inc. MTN price target from $195 to $185. Macquarie analyst Paul Golding maintained a Neutral rating. Vail Resorts shares closed at $165.42 on Tuesday. See how other analysts view this stock.
Wedbush cut the price target for Arvinas, Inc. ARVN from $57 to $12. Wedbush analyst Robert Driscoll downgraded the stock from Outperform to Neutral. Arvinas shares settled at $8.30 on Tuesday. See how other analysts view this stock.
Citigroup raised Core Laboratories Inc. CLB price target from $15 to $16. Citigroup analyst Scott Gruber upgraded the stock from Sell to Neutral. Core Laboratories shares closed at $14.62 on Tuesday. See how other analysts view this stock.